The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| PTC THERAPEUTICS INC | Com | 69366J200 | 277 | 8,180 | SH | DFND | 0 | 277 | 0 | 0 | |
| SANOFI-AVENTIS | Com | 80105N105 | 6,950 | 150,000 | SH | DFND | 0 | 6,950 | 0 | 0 | |
| SANOFI-AVENTIS | Com | 80105N105 | 13,899 | 300,000 | SH | DFND | 1 | 13,899 | 0 | 0 | |
| NEWTEK BUSINESS SERVICES INC | Com | 652526203 | 386 | 17,094 | SH | DFND | 1 | 386 | 0 | 0 | |